Leucine Supplementation and Skeletal Muscle Disuse
Not Applicable
Completed
- Conditions
- Disuse Atrophy
- Interventions
- Dietary Supplement: LeucineDietary Supplement: Placebo
- Registration Number
- NCT01192009
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 22
Inclusion Criteria
- Clinical diagnosis of anterior cruciate ligament injury
- Physically active
- Must be able to swallow tablets
- Non-smokers
- Do not use nutritional supplements
Read More
Exclusion Criteria
- Post-surgical complications
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Immobilization and Leucine Leucine - Immobilization and Placebo Placebo -
- Primary Outcome Measures
Name Time Method Skeletal muscle structure (cross-sectional area) 2 weeks
- Secondary Outcome Measures
Name Time Method Molecular signalling pathways (hypertrophy, atrophy, and inflammation) 2 weeks
Trial Locations
- Locations (1)
University of São Paulo - School of Physical Education and Sports
🇧🇷São Paulo, Brazil